Ultralife Corporation (ULBI) Stock Overview
Explore Ultralife Corporation’s financial performance, market position, analyst ratings, and future outlook.
Ultralife Corporation (ULBI)
Key Financials
Key Financials
Market Cap
262.5M
P/E Ratio
-84.18
EPS (TTM)
$0.09
ROE
-0.02%
ULBI Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Ultralife Corporation (NASDAQ: ULBI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Ultralife Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ULBI on the NASDAQ shows an RSI of 92.91, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $4.43 for the NASDAQ listing.
Key metrics behind Ultralife Corporation's NASDAQ-traded stock include a P/E ratio of -84.18 and a market capitalization of 262.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ULBI on the NASDAQ.